Global Insomnia Therapeutics Market 2025-2029

Description

List of Tables

The insomnia therapeutics market is forecasted to grow by USD 1,198.6 mn during 2024-2029, accelerating at a CAGR of 5.9% during the forecast period. The report on the insomnia therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of insomnia, technological advancements in diagnostics and treatment, and rising healthcare expenditure and insurance coverage.

Market Scope
Base Year	2025
End Year	2029
Series Year	2025-2029
Growth Momentum	Accelerate
YOY 2025	5.5%
CAGR	5.9%
Incremental Value	$1,198.6 mn

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's insomnia therapeutics market is segmented as below:

By Type

Drug
Devices

By Distribution Channel

Prescription
OTC

By Drug Class

Non-benzodiazepines
Benzodiazepines
Antidepressants
Orexin receptor antagonists
Melatonin receptor agonists

By Geographical Landscape

North America
Asia
Europe
Rest of World (ROW)

This study identifies the increased focus on non-pharmacological treatments as one of the prime reasons driving the insomnia therapeutics market growth during the next few years. Also, technological advancements in sleep monitoring and tracking and growing awareness and acceptance of importance of mental health will lead to sizable demand in the market.

The report on the insomnia therapeutics market covers the following areas:

Insomnia Therapeutics Market sizing
Insomnia Therapeutics Market forecast
Insomnia Therapeutics Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading insomnia therapeutics market vendors that include Abbott Laboratories, Astellas Pharma Inc., Aurobindo Pharma Ltd., Eisai Co. Ltd., Electromedical Products International Inc., Idorsia Pharmaceuticals Ltd., INNOVATIVE NEUROLOGICAL DEVICES LLC, Mallinckrodt Plc, MEDICE Arzneimittel Putter GmbH and Co. KG, Merck and Co. Inc., Neurim Pharmaceuticals Ltd., Pfizer Inc., Sanofi SA, Sumitomo Pharma Co. Ltd., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd., Vanda Pharmaceuticals Inc., and Viatris Inc.. Also, the insomnia therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR76428

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Distribution Channel
- Executive Summary - Chart on Market Segmentation by Drug Class
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
- Overview on factors of disruption
2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
3.2 Market characteristics
- Market characteristics analysis
3.3 Value chain analysis
- Value chain analysis

4 Market Sizing

4.1 Market definition
- Offerings of companies included in the market definition
4.2 Market segment analysis
- Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ million)
- Data Table on Global - Market size and forecast 2024-2029 ($ million)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

5.1 Global Insomnia Therapeutics Market 2019 - 2023
- Historic Market Size - Data Table on Global Insomnia Therapeutics Market 2019 - 2023 ($ million)
5.2 Type segment analysis 2019 - 2023
- Historic Market Size - Type Segment 2019 - 2023 ($ million)
5.3 Distribution Channel segment analysis 2019 - 2023
- Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
5.4 Drug Class segment analysis 2019 - 2023
- Historic Market Size - Drug Class Segment 2019 - 2023 ($ million)
5.5 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.6 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

6.1 The impact of AI in the global insomnia therapeutics market

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Type

8.1 Market segments
- Chart on Type - Market share 2024-2029 (%)
- Data Table on Type - Market share 2024-2029 (%)
8.2 Comparison by Type
- Chart on Comparison by Type
- Data Table on Comparison by Type
8.3 Drug - Market size and forecast 2024-2029
- Chart on Drug - Market size and forecast 2024-2029 ($ million)
- Data Table on Drug - Market size and forecast 2024-2029 ($ million)
- Chart on Drug - Year-over-year growth 2024-2029 (%)
- Data Table on Drug - Year-over-year growth 2024-2029 (%)
8.4 Devices - Market size and forecast 2024-2029
- Chart on Devices - Market size and forecast 2024-2029 ($ million)
- Data Table on Devices - Market size and forecast 2024-2029 ($ million)
- Chart on Devices - Year-over-year growth 2024-2029 (%)
- Data Table on Devices - Year-over-year growth 2024-2029 (%)
8.5 Market opportunity by Type
- Market opportunity by Type ($ million)
- Data Table on Market opportunity by Type ($ million)

9 Market Segmentation by Distribution Channel

9.1 Market segments
- Chart on Distribution Channel - Market share 2024-2029 (%)
- Data Table on Distribution Channel - Market share 2024-2029 (%)
9.2 Comparison by Distribution Channel
- Chart on Comparison by Distribution Channel
- Data Table on Comparison by Distribution Channel
9.3 Prescription - Market size and forecast 2024-2029
- Chart on Prescription - Market size and forecast 2024-2029 ($ million)
- Data Table on Prescription - Market size and forecast 2024-2029 ($ million)
- Chart on Prescription - Year-over-year growth 2024-2029 (%)
- Data Table on Prescription - Year-over-year growth 2024-2029 (%)
9.4 OTC - Market size and forecast 2024-2029
- Chart on OTC - Market size and forecast 2024-2029 ($ million)
- Data Table on OTC - Market size and forecast 2024-2029 ($ million)
- Chart on OTC - Year-over-year growth 2024-2029 (%)
- Data Table on OTC - Year-over-year growth 2024-2029 (%)
9.5 Market opportunity by Distribution Channel
- Market opportunity by Distribution Channel ($ million)
- Data Table on Market opportunity by Distribution Channel ($ million)

10 Market Segmentation by Drug Class

10.1 Market segments
- Chart on Drug Class - Market share 2024-2029 (%)
- Data Table on Drug Class - Market share 2024-2029 (%)
10.2 Comparison by Drug Class
- Chart on Comparison by Drug Class
- Data Table on Comparison by Drug Class
10.3 Non-benzodiazepines - Market size and forecast 2024-2029
- Chart on Non-benzodiazepines - Market size and forecast 2024-2029 ($ million)
- Data Table on Non-benzodiazepines - Market size and forecast 2024-2029 ($ million)
- Chart on Non-benzodiazepines - Year-over-year growth 2024-2029 (%)
- Data Table on Non-benzodiazepines - Year-over-year growth 2024-2029 (%)
10.4 Benzodiazepines - Market size and forecast 2024-2029
- Chart on Benzodiazepines - Market size and forecast 2024-2029 ($ million)
- Data Table on Benzodiazepines - Market size and forecast 2024-2029 ($ million)
- Chart on Benzodiazepines - Year-over-year growth 2024-2029 (%)
- Data Table on Benzodiazepines - Year-over-year growth 2024-2029 (%)
10.5 Antidepressants - Market size and forecast 2024-2029
- Chart on Antidepressants - Market size and forecast 2024-2029 ($ million)
- Data Table on Antidepressants - Market size and forecast 2024-2029 ($ million)
- Chart on Antidepressants - Year-over-year growth 2024-2029 (%)
- Data Table on Antidepressants - Year-over-year growth 2024-2029 (%)
10.6 Orexin receptor antagonists - Market size and forecast 2024-2029
- Chart on Orexin receptor antagonists - Market size and forecast 2024-2029 ($ million)
- Data Table on Orexin receptor antagonists - Market size and forecast 2024-2029 ($ million)
- Chart on Orexin receptor antagonists - Year-over-year growth 2024-2029 (%)
- Data Table on Orexin receptor antagonists - Year-over-year growth 2024-2029 (%)
10.7 Melatonin receptor agonists - Market size and forecast 2024-2029
- Chart on Melatonin receptor agonists - Market size and forecast 2024-2029 ($ million)
- Data Table on Melatonin receptor agonists - Market size and forecast 2024-2029 ($ million)
- Chart on Melatonin receptor agonists - Year-over-year growth 2024-2029 (%)
- Data Table on Melatonin receptor agonists - Year-over-year growth 2024-2029 (%)
10.8 Market opportunity by Drug Class
- Market opportunity by Drug Class ($ million)
- Data Table on Market opportunity by Drug Class ($ million)

11 Customer Landscape

11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

12.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2024-2029 (%)
- Data Table on Market share By Geographical Landscape 2024-2029 (%)
12.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
12.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ million)
- Data Table on North America - Market size and forecast 2024-2029 ($ million)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
12.4 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ million)
- Data Table on Asia - Market size and forecast 2024-2029 ($ million)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
12.5 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ million)
- Data Table on Europe - Market size and forecast 2024-2029 ($ million)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
12.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
12.7 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ million)
- Data Table on US - Market size and forecast 2024-2029 ($ million)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
12.8 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ million)
- Data Table on Canada - Market size and forecast 2024-2029 ($ million)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
12.9 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ million)
- Data Table on China - Market size and forecast 2024-2029 ($ million)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
12.10 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ million)
- Data Table on Japan - Market size and forecast 2024-2029 ($ million)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
12.11 Mexico - Market size and forecast 2024-2029
- Chart on Mexico - Market size and forecast 2024-2029 ($ million)
- Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
- Chart on Mexico - Year-over-year growth 2024-2029 (%)
- Data Table on Mexico - Year-over-year growth 2024-2029 (%)
12.12 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ million)
- Data Table on India - Market size and forecast 2024-2029 ($ million)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
12.13 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ million)
- Data Table on Germany - Market size and forecast 2024-2029 ($ million)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
12.14 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ million)
- Data Table on UK - Market size and forecast 2024-2029 ($ million)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
12.15 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ million)
- Data Table on France - Market size and forecast 2024-2029 ($ million)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
12.16 South Korea - Market size and forecast 2024-2029
- Chart on South Korea - Market size and forecast 2024-2029 ($ million)
- Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
- Chart on South Korea - Year-over-year growth 2024-2029 (%)
- Data Table on South Korea - Year-over-year growth 2024-2029 (%)
12.17 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)

13 Drivers, Challenges, and Opportunity/Restraints

13.1 Market drivers
13.2 Market challenges
13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
13.4 Market opportunities/restraints

14 Competitive Landscape

14.1 Overview
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
- Overview on factors of disruption
14.4 Industry risks
- Impact of key risks on business

15 Competitive Analysis

15.1 Companies profiled
- Companies covered
15.2 Company ranking index
- Company ranking index
15.3 Market positioning of companies
- Matrix on companies position and classification
15.4 Astellas Pharma Inc.
- Astellas Pharma Inc. - Overview
- Astellas Pharma Inc. - Product / Service
- Astellas Pharma Inc. - Key offerings
- SWOT
15.5 Aurobindo Pharma Ltd.
- Aurobindo Pharma Ltd. - Overview
- Aurobindo Pharma Ltd. - Product / Service
- Aurobindo Pharma Ltd. - Key offerings
- SWOT
15.6 Eisai Co. Ltd.
- Eisai Co. Ltd. - Overview
- Eisai Co. Ltd. - Business segments
- Eisai Co. Ltd. - Key offerings
- Eisai Co. Ltd. - Segment focus
- SWOT
15.7 Electromedical Products International Inc.
- Electromedical Products International Inc. - Overview
- Electromedical Products International Inc. - Product / Service
- Electromedical Products International Inc. - Key offerings
- SWOT
15.8 Idorsia Pharmaceuticals Ltd.
- Idorsia Pharmaceuticals Ltd. - Overview
- Idorsia Pharmaceuticals Ltd. - Product / Service
- Idorsia Pharmaceuticals Ltd. - Key offerings
- SWOT
15.9 INNOVATIVE NEUROLOGICAL DEVICES LLC
- INNOVATIVE NEUROLOGICAL DEVICES LLC - Overview
- INNOVATIVE NEUROLOGICAL DEVICES LLC - Product / Service
- INNOVATIVE NEUROLOGICAL DEVICES LLC - Key offerings
- SWOT
15.10 Mallinckrodt Plc
- Mallinckrodt Plc - Overview
- Mallinckrodt Plc - Business segments
- Mallinckrodt Plc - Key news
- Mallinckrodt Plc - Key offerings
- Mallinckrodt Plc - Segment focus
- SWOT
15.11 Merck and Co. Inc.
- Merck and Co. Inc. - Overview
- Merck and Co. Inc. - Business segments
- Merck and Co. Inc. - Key news
- Merck and Co. Inc. - Key offerings
- Merck and Co. Inc. - Segment focus
- SWOT
15.12 Neurim Pharmaceuticals Ltd.
- Neurim Pharmaceuticals Ltd. - Overview
- Neurim Pharmaceuticals Ltd. - Product / Service
- Neurim Pharmaceuticals Ltd. - Key offerings
- SWOT
15.13 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- SWOT
15.14 Sanofi SA
- Sanofi SA - Overview
- Sanofi SA - Business segments
- Sanofi SA - Key news
- Sanofi SA - Key offerings
- Sanofi SA - Segment focus
- SWOT
15.15 Sumitomo Pharma Co. Ltd.
- Sumitomo Pharma Co. Ltd. - Overview
- Sumitomo Pharma Co. Ltd. - Business segments
- Sumitomo Pharma Co. Ltd. - Key offerings
- Sumitomo Pharma Co. Ltd. - Segment focus
- SWOT
15.16 Sun Pharmaceutical Industries Ltd.
- Sun Pharmaceutical Industries Ltd. - Overview
- Sun Pharmaceutical Industries Ltd. - Product / Service
- Sun Pharmaceutical Industries Ltd. - Key news
- Sun Pharmaceutical Industries Ltd. - Key offerings
- SWOT
15.17 Takeda Pharmaceutical Co. Ltd.
- Takeda Pharmaceutical Co. Ltd. - Overview
- Takeda Pharmaceutical Co. Ltd. - Product / Service
- Takeda Pharmaceutical Co. Ltd. - Key news
- Takeda Pharmaceutical Co. Ltd. - Key offerings
- SWOT
15.18 Vanda Pharmaceuticals Inc.
- Vanda Pharmaceuticals Inc. - Overview
- Vanda Pharmaceuticals Inc. - Product / Service
- Vanda Pharmaceuticals Inc. - Key offerings
- SWOT

16 Appendix

16.1 Scope of the report
16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
16.3 Currency conversion rates for US$
- Currency conversion rates for US$
16.4 Research methodology
- Research methodology
16.5 Data procurement
- Information sources
16.6 Data validation
- Data validation
16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
16.8 Data synthesis
- Data synthesis
16.9 360 degree market analysis
- 360 degree market analysis
16.10 List of abbreviations
- List of abbreviations